DR. REDDY'S LABORATORIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,293 INR | -0.88% |
|
-0.06% | +8.55% |
| 04:57am | Indian shares set to open higher on Fed rate-cut hopes | RE |
| May. 03 | Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, End Week Over 2% Higher | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 279B 3.34B | Sales 2025 * | 299B 3.58B | Capitalization | 1,057B 12.67B |
|---|---|---|---|---|---|
| Net income 2024 * | 54.64B 655M | Net income 2025 * | 56.74B 680M | EV / Sales 2024 * | 3.55 x |
| Net cash position 2024 * | 67.94B 814M | Net cash position 2025 * | 107B 1.28B | EV / Sales 2025 * | 3.18 x |
| P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
18.6
x | Employees | 25,863 |
| Yield 2024 * |
0.64% | Yield 2025 * |
0.69% | Free-Float | 91.52% |
More Fundamentals
* Assessed data
More news
Latest transcript on Dr. Reddy's Laboratories Limited
More recommendations
More press releases
More news
| 1 day | -0.88% | ||
| 1 week | -0.06% | ||
| Current month | +1.44% | ||
| 1 month | +1.93% | ||
| 3 months | +2.06% | ||
| 6 months | +17.90% | ||
| Current year | +8.55% |
1 week
6 185.00
6 419.90
1 month
5 880.806 419.90
Current year
5 520.656 505.90
1 year
4 384.056 505.90
3 years
3 654.006 505.90
5 years
2 351.206 505.90
10 years
1 872.956 505.90
| Managers | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 57 | 18-04-01 |
Parag Agarwal
DFI | Director of Finance/CFO | - | 20-11-01 |
| Chairman | 56 | 93-01-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gunupati Prasad
CHM | Chairman | 63 | 86-04-07 |
| Chairman | 56 | 93-01-17 | |
Kalpana Morparia
BRD | Director/Board Member | 74 | 07-06-04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 6,293 | -0.88% | 452 750 |
| 24-05-03 | 6,350 | +0.99% | 581,368 |
| 24-05-02 | 6,288 | +1.34% | 626,953 |
| 24-04-30 | 6,204 | -1.47% | 381,304 |
| 24-04-29 | 6,297 | +0.72% | 297,106 |
Delayed Quote NSE India S.E., May 06, 2024 at 06:10 am EDT
More quotes
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-05-06
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
6,350
INR
Average target price
6,005
INR
Spread / Average Target
-5.43%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.08% | 662B | |
| +22.05% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 289B | |
| +13.68% | 234B | |
| +4.55% | 198B | |
| -10.67% | 194B | |
| +8.08% | 167B |
- Stock Market
- Equities
- DRREDDY Stock
- DRREDDY Stock